Why does cell-to-cell propagation remain a critical yet underoptimized process in therapeutic delivery systems? Despite 83% of gene therapies relying on intercellular transmission mechanisms, the International Journal of Nanomedicine (March 2024) reports a staggering 62% efficiency loss during viral vector propagation between host cells. This raises an urgent question: How can we transform biological limitations into engineering opportunities?
Enter your inquiry details, We will reply you in 24 hours.
Brand promise worry-free after-sales service